Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | PYGB | P11216 | 1/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16285372 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL2429112 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL19603336 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL229613 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL5862474 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL3144972 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL4703623 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL8361874 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22026379 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22047951 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3783093-B1 | METHOD FOR PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | INNOVATION HAMMER LLC (US) | 2025-04-16 | — | — | EP | claimed |
| US-11147219-B2 | Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, process and systems for the same | INNOVATION HAMMER, LLC (US) | 2021-10-19 | — | — | US | claimed |
| EP-3783093-A2 | METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | Innovation Hammer LLC (US) | 2021-02-24 | — | — | EP | claimed |
| US-20180325045-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2018-11-15 | — | — | US | claimed |
| CN-105218600-B | synthetic method of 2,3,4, 6-O-acetyl- α -D-mannopyranose trichloroacetimidate | 江苏省计量科学研究院 | 2018-06-08 | — | — | CN | claimed |
| US-20170164562-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2017-06-15 | — | — | US | claimed |
| CN-105218600-A | Synthetic method of 2,3,4, 6-O-acetyl-alpha-D-mannopyranose trichloroacetimidate | JIANGSU INST METROLOGY | 2016-01-06 | — | — | CN | claimed |
| EP-3783093-B1 | METHOD FOR PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | INNOVATION HAMMER LLC (US) | 2025-04-16 | — | — | EP | disclosed |
| CN-113226271-B | Oral care compositions | 高露洁-棕榄公司 | 2023-07-25 | — | — | CN | disclosed |
| US-20230060588-A1 | METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS | Glycure LLC (US) | 2023-03-02 | — | — | US | disclosed |
| US-11147219-B2 | Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, process and systems for the same | INNOVATION HAMMER, LLC (US) | 2021-10-19 | — | — | US | disclosed |
| EP-3783093-A2 | METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | Innovation Hammer LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-2782990-B1 | METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | INNOVATION HAMMER LLC (US) | 2020-10-07 | — | — | EP | disclosed |
| EP-2782990-A1 | METHODS AND SYSTEMS FOR GROWING PLANTS USING SILICATE-BASED SUBSTRATES, CULTIVATION OF ENHANCED PHOTOSYNTHETIC PRODUCTIVITY AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES FOR ENDOGENOUS GLYCOPYRANOSYL-PROTEIN DERIVATIVES, AND FORMULATIONS, PROCESSES AND SYSTEMS FOR THE SAME | Nonomura, Arthur M. (US) | 2014-10-01 | — | — | EP | disclosed |
| EP-2782938-A1 | HIGH ACTIVITY CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND METHOD OF USING THE SAME | BASF Corporation (US) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013078106-A1 | METHODS AND SYSTEMS FOR GROWING PLANTS USING SILICATE-BASED SUBSTRATES, CULTIVATION OF ENHANCED PHOTOSYNTHETIC PRODUCTIVITY AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES FOR ENDOGENOUS GLYCOPYRANOSYL-PROTEIN DERIVATIVES, AND FORMULATIONS, PROCESSES AND SYSTEMS FOR THE SAME | NONOMURA ARTHUR M (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2013077837-A1 | HIGH ACTIVITY CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND METHOD OF USING THE SAME | BASF CORPORATION (US) | 2013-05-30 | — | — | WO | disclosed |
| US-8298773-B2 | Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes | VUSKOVIC MARKO (US) | 2012-10-30 | — | — | US | disclosed |
| US-20100075344-A1 | Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes | VUSKOVIC MARKO | 2010-03-25 | — | — | US | disclosed |
| EP-0461556-A1 | Epipodophyllotoxin glycosides | Bristol-Myers Squibb Company (US) | 1991-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230060588-A1 | METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS | FUT5, FUT6, SIGLEC7 | SLC28A3 2995/4885L3MBTL1 2264/4885MAPT 4507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.